Atrial fibrillation - first patient treated in Sweden using robotic technology

Atrial fibrillation - first patient treated in Sweden using robotic technology

Arrhythmia Center Stockholm has today performed the first treatment of atrial
fibrillation in the new facility at Södersjukhuset in Stockholm. Arrhythmia
Center Stockholm is a private initiative that has been started as part of the
unique collaboration between Global Health Partner and Södersjukhuset. This
venture increases the opportunities for meeting a growing need for care from a
patient group that today greatly suffers from long waiting times within hospital
care.

Arrhythmia Center Stockholm is a new centre for the treatment of patients with
disturbances of the heart's rhythm, so-called arrhythmias. The facility is
located at Södersjukhuset and is run in close collaboration with
Södersjukhuset's own cardiological department. “We at Södersjukhuset are pleased
about this opportunity
for collaboration. We look forward to working together both with regard to
patients and research and development,” says Anna Nergårdh, Head of the
Cardiology Department at Södersjukhuset.

This is the first clinic in Sweden to use magnetic navigation, Stereotaxis, to
perform so-called ablation treatment. The technology gives greater precision
during the intervention, less risk of complications and a reduction in x-ray
exposure. “The robotic technology is a big step forward in the treatment of
patients with atrial fibrillation,” says the medically responsible Associate
Professor, Anders Englund,

Hospital heart care in Sweden is today grappling with very long waiting times, a
lack of specialist competence and equipment for the treatment of, amongst other
things, atrial fibrillation. There is a great need for hospital care among
patients with atrial fibrillation and several serious complications such as
stroke and heart failure may set in. 

The new clinic will be able to perform 400 treatments per year and will take
both publicly and privately financed patients from all of Sweden. Today a total
of 2,000 treatments per year are performed in the country.

”We have managed to engage some of Sweden's most experienced arrhythmia doctors
and have great hopes that we will be able to contribute to the development of
arrhythmia care,” says Per Båtelson, Global Health Partner's CEO.

For further information on this venture, see www.arytmicenter.se.

Ablations have been performed for nearly 20 years now on patients with
congenital arrhythmia disturbances due to one or more accessory pathways. The
method has been developed over the past five years and today is also an
established treatment method for patients with atrial fibrillation. In the
recently published national guidelines for hospital heart care, ablation of
atrial fibrillation is given high priority, which means that it is estimated
that the demand for this intervention will increase rapidly over the coming
years.

6 May 2009
Gothenburg
Per Båtelson, CEO Global Health Partner

For further information, please contact:
Per Båtelson, CEO Global Health Partner, tel: +46 (0)705-95 57 00
Ulrika Swegmark, Project Manager Global Health Partner, tel: +46 (0)707-52 45 94

Global Health Partner operates specialist clinics that focus on selected
treatment areas (Spine, Dental, Bariatrics and Orthopaedics) using a business
model unique in the Swedish healthcare sector in which leading physicians become
partners and shareholders. Operating clinics with a high patient volume in a
particular treatment area leads to a higher level of efficiency and quality.
This concept of “Quality through Specialisation” is the foundation for the
clinics and Global Health Partner's operations. Global Health Partner's shares
are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation
“GHP.”

Global Health Partner AB (publ) | www.globalhealthpartner.com
Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden
Tel +46 (0)31-712 53 00 | Fax +46 (0)31-313 13 21

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.